Cognition Therapeutics, Inc. (CGTX) Financial Ratios Annual - Discounting Cash Flows
CGTX
Cognition Therapeutics, Inc.
CGTX (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
Price Ratios
Price to Earnings Ratio -2.92 -0.82 -2.15 80.43 -11.99 -27.81 -40.29
Price to Sales Ratio 0 0 0 0 0 0 0
Price to Book Ratio 2.24 1.49 2.27 1.51 2.74 -4.11 -4.79
Price to Free Cash Flow Ratio -2.62 -0.978 -3.43 -3.26 -38.41 -81.36 -86.41
Price to Operating Cash Flow Ratio -2.77 -0.979 -3.46 -3.29 -38.69 -81.6 -90.42
Price Earnings to Growth Ratio -0.103 0.705 -0.133 58.71 -0.366 -0.387 0
EV to EBITDA 0.884 0.451 0.568 0.925 -0.443 -0.226
Liquidity Ratios
Current Ratio 6.44 2.65 3.37 6.11 7.5 2.13 1.94
Quick Ratio 6.44 2.65 3.37 6.11 7.5 2.13 1.91
Cash Ratio 5.98 2.24 2.94 5.33 6.96 1.6 0.785
Debt Ratio 0.009 0.027 0.035 0.029 0 1.81 0.925
Debt to Equity Ratio 0.01 0.043 0.051 0.037 0 -0.188 -0.118
Long Term Debt to Capitalization 0 0 0 0 0 -0.232 -0.134
Total Debt to Capitalization 0.01 0.042 0.048 0.035 0 -0.232 -0.134
Interest Coverage Ratio -3,450 -2,159 0 -1,555 -32.02 -9.94 -17.41
Cash Flow to Debt Ratio -77.72 -34.98 -12.94 -12.54 0 -0.267 -0.449
Margins
Gross Profit Margin 0% 0% 0% 0% 0% 0% 0%
Operating Profit Margin 0% 0% 0% 0% 0% 0% 0%
Pretax Profit Margin 0% 0% 0% 0% 0% 0% 0%
Net Profit Margin 0% 0% 0% 0% 0% 0% 0%
Operating Cash Flow Margin 0% 0% 0% 0% 0% 0% 0%
Free Cash Flow Margin 0% 0% 0% 0% 0% 0% 0%
Return
Return on Assets -64.49% -112.4% -73.34% 1.5% -19.81% -141.5% -93.22%
Return on Equity -150.1% -181.2% -105.4% 1.88% -22.85% 14.77% 11.9%
Return on Capital Employed -122.1% -282.7% -202.9% -102.2% -55.78% -449.9% -472.2%
Return on Invested Capital 0% 0% 0% 0% 0% 0% 0%
Turnover Ratios
Receivables Turnover Ratio 0 0 0 0 0 0 0
Payables Turnover Ratio 0.074 0 0 0.073 0 0.049 0.034
Inventory Turnover Ratio 0 0 0 0 0 0 0.692
Fixed Asset Turnover Ratio 0 0 0 0 0 0 0
Asset Turnover Ratio 0 0 0 0 0 0 0
Per Share Items ()
Revenue Per Share 0 0 0 0 0 0 0
Operating Cash Flow Per Share -0.379 -0.717 -0.534 -0.639 -0.163 -0.156 -0.141
Free Cash Flow Per Share -0.379 -0.717 -0.539 -0.645 -0.165 -0.157 -0.148
Cash & Short Term Investments 0.511 0.629 0.998 1.43 2.46 0.237 0.132
Earnings Per Share 0 0 0 0 0 0 0
EBITDA Per Share -0.572 -1.35 -1.68 -1.49 -1.28 -0.789 -0.809
Dividend Per Share 0 0 0 0 0 0 0
Enterprise Value Per Share -0.506 -0.609 -0.957 -1.38 0 0.349 0.183
Book Value Per Share 0 0 0 0 0 0 0
Price Per Share 0 0 0 0 0 0 0
Effective Tax Rate 0% 0% 0% 103.5% 0% 0% 0%
Short Term Coverage Ratio -175.8 -102.1 -29.44 -29.23 0 0 0
Capital Expenditure Coverage Ratio -29,533 -7,118 -109 -108.4 -134.5 -343.3 -21.51
EBIT Per Revenue 0 0 0 0 0 0 0
EBITDA Per Revenue None None None None None None None
Days of Sales Outstanding 0 0 0 0 0 0 0
Days of Inventory Outstanding 0 0 0 0 0 0 527.2
Days of Payables Outstanding 4,948 0 0 4,995 0 7,460 10,621
Cash Conversion Cycle -4,948 0 0 -4,995 0 -7,460 -10,094
Cash Conversion Ratio 0 0 0 0 0 0 0
Free Cash Flow to Earnings 0 0 0 0 0 0 0
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program